Delivering Rare Disease Therapies to Patients in Need

Bill Sibold, executive vice president of Sanofi Genzyme and president of Sanofi North America, discusses the company’s Humanitarian Aid Program, how it works; and how it overcomes the regulatory, infrastructure, and medical challenges of delivering these treatments to patients around the globe.